Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XF5P
|
|||
| Former ID |
DNC009136
|
|||
| Drug Name |
(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine
|
|||
| Synonyms |
CHEMBL469809; (R)-3-(naphthalen-2-ylmethoxy)pyrrolidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H17NO
|
|||
| Canonical SMILES |
C1CNCC1OCC2=CC3=CC=CC=C3C=C2
|
|||
| InChI |
1S/C15H17NO/c1-2-4-14-9-12(5-6-13(14)3-1)11-17-15-7-8-16-10-15/h1-6,9,15-16H,7-8,10-11H2/t15-/m1/s1
|
|||
| InChIKey |
IQZVBBALTJFFCB-OAHLLOKOSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.